O
OrbiMed Portfolio holdings
AUM
$4.17B
1-Year Est. Return
30.9%
1 Year Est. Return
+30.9%
AUM
$4.17B
AUM Growth
+$193M
(+4.9%)
Holding
120
Top Buys
| 1 | +$52.2M | |
| 2 | +$48.2M | |
| 3 | +$46.9M | |
| 4 |
Oric Pharmaceuticals
ORIC
|
+$32.9M |
| 5 |
ABVX
Abivax
ABVX
|
+$32.3M |
Top Sells
| 1 | +$105M | |
| 2 | +$93.6M | |
| 3 | +$81.8M | |
| 4 |
Boston Scientific
BSX
|
+$37.5M |
| 5 |
Cytokinetics
CYTK
|
+$35.6M |
Sector Composition
| 1 | Healthcare | 99.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMMB
101
Chemomab Therapeutics
CMMB
$16.1M
| – | – |
-235,248
|
|
||
102
Catalyst Pharmaceutical
CPRX
$2.88B
| – | – |
-416,900
|
|
||
|
103
Cytokinetics
CYTK
$8.33B
| – | – |
-1,077,000
|
|
||
104
enGene Holdings
ENGN
$540M
| – | – |
-677,977
|
|
||
105
INmune Bio
INMB
$46.3M
| – | – |
0
|
|
||
|
ITOS
106
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-700,000
|
|
||
107
Pfizer
PFE
$146B
| – | – |
0
|
|
||
108
Scholar Rock
SRRK
$4.49B
| – | – |
0
|
|
||
109
TG Therapeutics
TGTX
$5.28B
| – | – |
0
|
|
||
110
Tenet Healthcare
THC
$19.1B
| – | – |
-465,000
|
|
||
|
THRD
111
DELISTED
Third Harmonic Bio
THRD
| – | – |
-5,779,071
|
|
||
|
TSBX
112
DELISTED
Turnstone Biologics
TSBX
| – | – |
-3,099,265
|
|
||
113
Tyra Biosciences
TYRA
$1.2B
| – | – |
-804,603
|
|
||
114
UnitedHealth
UNH
$299B
| – | – |
-336,300
|
|
||
115
Vertex Pharmaceuticals
VRTX
$110B
| – | – |
-210,287
|
|
||
116
Zai Lab
ZLAB
$2.26B
| – | – |
-231,000
|
|
||
|
LSB
117
DELISTED
LakeShore Biopharma
LSB
| – | – |
-54,799
|
|
||
118
AbCellera Biologics
ABCL
$1.12B
| – | – |
-3,344,568
|
|